Credit Suisse Ag Fibrogen Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $74,291 - $614,323	29,836 Added 39.12%	106,095 $286,000
Q1 2023 May 10, 2023	BUY	$15.95 - $25.18 $23,031 - $36,359	1,444 Added 1.93%	76,259 $1.42 Million
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $27,415 - $36,630	-2,066 Reduced 2.69%	74,815 $1.2 Million
Q3 2022 Nov 10, 2022	BUY	$11.4 - $14.6 $149,351 - $191,274	13,101 Added 20.54%	76,881 $1 Million
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $26,972 - $44,025	-3,397 Reduced 5.06%	63,780 $674,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $80,065 - $111,838	6,661 Added 11.01%	67,177 $807,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $89,111 - $138,109	-8,974 Reduced 12.91%	60,516 $854,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $54,890 - $143,642	-5,392 Reduced 7.2%	69,490 $710,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $159,850 - $307,133	-8,608 Reduced 10.31%	74,882 $1.99 Million
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $2.31 Million - $4.16 Million	-74,666 Reduced 47.21%	83,490 $2.9 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $1.91 Million - $2.53 Million	51,624 Added 48.46%	158,156 $5.87 Million
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $22.6 Million - $25.4 Million	-557,911 Reduced 83.97%	106,532 $4.38 Million
Q2 2020 Aug 12, 2020	BUY	$32.57 - $42.83 $3.78 Million - $4.97 Million	115,994 Added 21.15%	664,443 $26.9 Million
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $1.41 Million - $2.77 Million	-60,373 Reduced 9.92%	548,449 $19.1 Million
Q4 2019 Feb 12, 2020	BUY	$34.58 - $48.06 $4.34 Million - $6.04 Million	125,608 Added 25.99%	608,822 $26.1 Million
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $1.24 Million - $1.62 Million	-33,426 Reduced 6.47%	483,214 $17.9 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $238,743 - $377,381	6,796 Added 1.33%	516,640 $23.3 Million
Q1 2019 May 14, 2019	SELL	$42.83 - $59.91 $2.51 Million - $3.51 Million	-58,555 Reduced 10.3%	509,844 $27.7 Million
Q4 2018 Feb 13, 2019	SELL	$37.97 - $60.16 $610,747 - $967,673	-16,085 Reduced 2.75%	568,399 $26.3 Million
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $4.88 Million - $5.83 Million	-86,757 Reduced 12.92%	584,484 $35.5 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $8.93 Million - $12.9 Million	-198,785 Reduced 22.85%	671,241 $42 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $35.9 Million - $48.8 Million	791,314 Added 1005.33%	870,026 $40.2 Million
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $319,491 - $457,721	-7,616 Reduced 8.82%	78,712 $3.73 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $1 Million - $1.62 Million	30,043 Added 53.38%	86,328 $4.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	56,285	56,285 $1.82 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account